Effects of LP28 on Immunity Enhancement in the Elderly

Launched by SYNBIO TECH INC. · Dec 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a probiotic called Lactobacillus plantarum LP28 to see if it can help improve the immune system in older adults. Researchers want to find out if taking this probiotic can reduce how often and how severely elderly people get common colds. The goal is to help older individuals stay healthier and feel better overall.

The study is looking for participants aged 18 to 80 who have had symptoms of a common cold or tonsillitis at least twice in the past year. However, people with certain health issues, such as liver or kidney diseases, mental illnesses, or allergies, are not eligible to join. If you decide to participate, you'll be helping to explore a potential way to enhance immune health in older adults. The trial is currently recruiting participants, so there’s an opportunity to get involved and contribute to important research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Those who had symptoms of common cold or tonsillitis at least twice in the past year.
• Exclusion Criteria:
• • People who have liver, kidney, immune, or neoplastic diseases diagnosed by doctor.
• • People with mental illnesses such as schizophrenia or depression.
• • People who have allergic rhinitis.
• • People who have a current condition of drug or alcohol dependence.
• • Any person is deemed inappropriate by the researcher for the clinical trial.